Pelthos Therapeutics Inc. (PTHS) stock
PTHSNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.84−0.31 (-4.34%)
Close on Nov 17, 2026Market cap $26.19MP/E –Yield –
Pelthos Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Pelthos Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -199.5%. For fiscal 2025 it was -257.9%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -257.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -150.1% | – |
| Q1 FY2026 | Mar 31, 2026 | -229.9% | – |
| Q4 FY2025 | Dec 31, 2025 | -230.7% | – |
| Q3 FY2025 | Sep 30, 2025 | -219.3% | – |
See a number that looks wrong?